Lionco Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings
About Lionco Pharmaceutical Group Co.,Ltd.
Lionco Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and sale of chemical drug preparations. The company specializes in a diverse range of therapeutic areas, including anti-infectives, digestive system treatments, cardiovascular health, and respiratory medicine. Its product portfolio primarily consists of high-end generic drugs, featuring formulations such as freeze-dried powder for injection, small-volume injections, and solid oral dosages. Lionco emphasizes technological innovation and quality control to provide clinical solutions for various medical conditions. The group operates multiple manufacturing facilities and maintains a comprehensive distribution network to serve healthcare providers and patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于变更签字注册会计师的公告 | 2026-03-02 | Chinese | |
| 2026年第一次临时股东会会议资料 | 2026-02-27 | Chinese | |
| 关于控股股东部分股份解除质押的公告 | 2026-02-11 | Chinese | |
| 东方金诚国际信用评估有限公司关于灵康药业集团股份有限公司2025年度业绩预亏的关注公告 | 2026-02-06 | Chinese | |
| 关于不向下修正“灵康转债”转股价格的公告 | 2026-01-30 | Chinese | |
| 第五届董事会第六次会议决议公告 | 2026-01-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 37830061 | 关于变更签字注册会计师的公告 | 2026-03-02 | Chinese | ||
| 37830058 | 2026年第一次临时股东会会议资料 | 2026-02-27 | Chinese | ||
| 37830055 | 关于控股股东部分股份解除质押的公告 | 2026-02-11 | Chinese | ||
| 37830053 | 东方金诚国际信用评估有限公司关于灵康药业集团股份有限公司2025年度业绩预亏的关注公告 | 2026-02-06 | Chinese | ||
| 37830049 | 关于不向下修正“灵康转债”转股价格的公告 | 2026-01-30 | Chinese | ||
| 37830046 | 第五届董事会第六次会议决议公告 | 2026-01-30 | Chinese | ||
| 37830044 | 关于召开2026年第一次临时股东会的通知 | 2026-01-30 | Chinese | ||
| 37830043 | 关于变更回购股份用途并注销暨减少注册资本的公告 | 2026-01-30 | Chinese | ||
| 37830041 | 2025年年度业绩预告 | 2026-01-23 | Chinese | ||
| 37830036 | 关于“灵康转债”预计满足转股价格修正条件的提示性公告 | 2026-01-23 | Chinese | ||
| 37830025 | 可转债转股结果暨股份变动公告 | 2026-01-05 | Chinese | ||
|
2025
4 filings
| |||||
| 37830017 | 关于“提质增效重回报”行动方案的公告 | 2025-12-30 | Chinese | ||
| 37830001 | 2025年第三次临时股东会决议公告 | 2025-12-24 | Chinese | ||
| 37830000 | 上海东方华银律师事务所关于灵康药业集团股份有限公司2025年第三次临时股东会之法律意见书 | 2025-12-24 | Chinese | ||
| 37829998 | 2025年第三次临时股东会会议资料 | 2025-12-18 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Lionco Pharmaceutical Group Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57767/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57767 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57767 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57767 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57767}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lionco Pharmaceutical Group Co.,Ltd. (id: 57767)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.